重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2014年
9期
1088-1089,1092
,共3页
刘富春%王国威%宋航%张浩%高军
劉富春%王國威%宋航%張浩%高軍
류부춘%왕국위%송항%장호%고군
高脂血症%老年人%辛伐他汀%治疗效果
高脂血癥%老年人%辛伐他汀%治療效果
고지혈증%노년인%신벌타정%치료효과
hyperlipidemia%elderly%simvastatin%treatment outcome
目的:研究辛伐他汀剂量对老年高脂血症患者疗效与安全性的影响。方法选取老年高脂血症患者120例,随机分为两组,每组60例,分别给予辛伐他汀10 mg/d(10 mg/d剂量组)和20 mg/d(20 mg/d剂量组),疗程3个月。在治疗前后检测患者总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)水平,并记录疗效和不良反应。结果治疗后,两组患者TC、TG、LDL-C、HDL-C均较治疗前有所改善,差异有统计学意义(P<0.05);且20 mg/d剂量组疗效优于10 mg/d剂量组,差异有统计学意义(P<0.05);两组患者不良反应发生率之间的差异无统计学意义(P>0.05)。结论20 mg/d剂量辛伐他汀对老年高脂血症患者疗效更好,且同样安全可靠。
目的:研究辛伐他汀劑量對老年高脂血癥患者療效與安全性的影響。方法選取老年高脂血癥患者120例,隨機分為兩組,每組60例,分彆給予辛伐他汀10 mg/d(10 mg/d劑量組)和20 mg/d(20 mg/d劑量組),療程3箇月。在治療前後檢測患者總膽固醇(TC)、三酰甘油(TG)、低密度脂蛋白膽固醇(LDL-C)、高密度脂蛋白膽固醇(HDL-C)水平,併記錄療效和不良反應。結果治療後,兩組患者TC、TG、LDL-C、HDL-C均較治療前有所改善,差異有統計學意義(P<0.05);且20 mg/d劑量組療效優于10 mg/d劑量組,差異有統計學意義(P<0.05);兩組患者不良反應髮生率之間的差異無統計學意義(P>0.05)。結論20 mg/d劑量辛伐他汀對老年高脂血癥患者療效更好,且同樣安全可靠。
목적:연구신벌타정제량대노년고지혈증환자료효여안전성적영향。방법선취노년고지혈증환자120례,수궤분위량조,매조60례,분별급여신벌타정10 mg/d(10 mg/d제량조)화20 mg/d(20 mg/d제량조),료정3개월。재치료전후검측환자총담고순(TC)、삼선감유(TG)、저밀도지단백담고순(LDL-C)、고밀도지단백담고순(HDL-C)수평,병기록료효화불량반응。결과치료후,량조환자TC、TG、LDL-C、HDL-C균교치료전유소개선,차이유통계학의의(P<0.05);차20 mg/d제량조료효우우10 mg/d제량조,차이유통계학의의(P<0.05);량조환자불량반응발생솔지간적차이무통계학의의(P>0.05)。결론20 mg/d제량신벌타정대노년고지혈증환자료효경호,차동양안전가고。
Objective To study the efficacy and safety of different simvastatin doses on hyperlipidemia in the elderly .Methods 120 patients with hyperlipidemia were randomly divided into two groups ,60 cases in each group ,patients were given simvastatin 10 mg/d(10 mg/d group) or 20 mg/d(20 mg/d group) .Data were collected before and after treatment ,including total cholesterol (TC) ,three acyl glycerin (TG) ,low density lipoprotein cholesterol (LDL-C) ,high density lipoprotein cholesterol (HDL-C) ,treat-ment efficacy and adverse reactions events .Results 3 month after treatment ,TC ,TG ,LDL-C and HDL-C were better than before treatment in both groups(P<0 .05);and the curative effect in 20 mg/d group was better than 10 mg/d group(P<0 .05) .There was no significant difference in incidence of adverse reactions events between the two groups (P>0 .05) .Conclusion 20 mg/d simvasta-tin is better than 10 mg/d simvastatin in efficacy of elderly patients with hyperlipidemia ,and offers a safe and reliable treatment .